{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T23:06:24Z","timestamp":1789686384224,"version":"4.0.1"},"reference-count":116,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":86,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Rare diseases (RDs) affect an estimated 7% of the global population and comprise ~7,000 heterogeneous conditions, most of which have a genetic etiology. Despite their collective burden, RDs pose major diagnostic challenges, often resulting in prolonged diagnostic odysseys with substantial clinical, emotional, and economic consequences. Next generation sequencing technologies such as whole exome (WES) and whole genome sequencing (WGS) have transformed RD diagnostics in high-resource settings. In contrast, the use of such technologies in Latin America remains uneven due to structural, regulatory, and economic constraints. In addition, the underrepresentation of admixed populations in genomic databases further complicates variant interpretation, reducing the diagnostic yield. In this context, we created the first genomic medicine program for rare diseases in Uruguay to address these challenges by implementing next-generation sequencing (NGS) strategies for diagnosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Material and methods<\/jats:title>\n                    <jats:p>Whole exome sequencing (WES) and whole genome sequencing (WGS) were performed on a cohort of 203 patients with suspected RD belonging to the Uruguayan public healthcare system. Variant prioritization was conducted using established bioinformatics pipelines integrating population frequency filtering, inheritance models, functional impact, and phenotype-driven clinical interpretation. Implementation of population-aware variant interpretation strategies was critical in this admixed population, helping to reduce false-positive findings arising from the underrepresentation of Latin American populations in global reference databases. This framework was built through sustained collaboration between academic institutions and healthcare providers, with a strong emphasis on local capacity building in clinical genetics, molecular diagnostics, and bioinformatics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>To date, we have analyzed a total of 203 patients: 172 using WES, 29 using WGS, and 11 using mitochondrial DNA sequencing (9 of whom were also analyzed by WES). The overall diagnostic yield was 48% for WES and 31% for WGS. The program significantly shortened diagnostic trajectories and enabled actionable clinical insights in a substantial proportion of cases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our experience shows that comprehensive genomic diagnostics for RDs can be successfully carried out in emerging genomic medicine settings through integrated workflows and sustained investment in human capital. This initiative represents a scalable model for other low income countries seeking to incorporate genomic medicine into public healthcare systems and highlights the importance of regional genomic data to improve diagnostic accuracy and equity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-026-04387-2","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T17:16:34Z","timestamp":1782321394000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Implementation of a medical genomics program for rare diseases in Uruguay"],"prefix":"10.1186","volume":"21","author":[{"given":"Camila","family":"Simoes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Fernanda","family":"Dom\u00ednguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soledad","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Moraes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Paula","family":"Frade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Brandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mart\u00edn","family":"Gra\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc\u00eda","family":"Sosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Fontenla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Tapi\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicol\u00e1s","family":"Dell\u2019Oca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaf","family":"Riess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Tort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Naya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00edctor","family":"Raggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5124-9250","authenticated-orcid":false,"given":"Lucia","family":"Spangenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,24]]},"reference":[{"key":"4387_CR1","unstructured":"\u201cOrphanet.\u201d. n.d. December 8, 2025. https:\/\/www.orpha.net\/."},{"issue":"October","key":"4387_CR2","doi-asserted-by":"publisher","first-page":"1028545","DOI":"10.3389\/fpubh.2022.1028545","volume":"10","author":"CCY Chung","year":"2022","unstructured":"Chung CCY, Chu ATW, Chung BHY, Hong Kong Genome Project, Annie Tsz Wai Chu, and Brian Hon Yin Chung. Rare disease emerging as a global public Health priority. Front Public Health. 2022;10(October):1028545. https:\/\/doi.org\/10.3389\/fpubh.2022.1028545.","journal-title":"Front Public Health"},{"issue":"2","key":"4387_CR3","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/s41431-019-0508-0","volume":"28","author":"S Nguengang","year":"2020","unstructured":"Nguengang S, Lambert DM, Olry A, Rodwell C, Gueydan C, Lanneau V, et al. Estimating cumulative point prevalence of rare Diseases: analysis of the Orphanet database. Eur J Hum Genet. 2020;28(2):165\u201373. https:\/\/doi.org\/10.1038\/s41431-019-0508-0.","journal-title":"Eur J Hum Genet"},{"issue":"6","key":"4387_CR4","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1002\/ajmg.a.61124","volume":"179","author":"CR Ferreira","year":"2019","unstructured":"Ferreira CR. The burden of Rare Diseases. Am J Med Genet Pt A. 2019;179(6):885\u201392. https:\/\/doi.org\/10.1002\/ajmg.a.61124.","journal-title":"Am J Med Genet Pt A"},{"key":"4387_CR5","unstructured":"Gonzaga-Jauregui C, Lupski J. (Eds.). Genomics of rare diseases: understanding disease genetics using genomic approaches. 2021. https:\/\/books.google.com\/books?hl=es%26lr=%26id=9nENEAAAQBAJ%26oi=fnd%26pg=PP1%26dq=Genomics+of+Rare+Diseases%26ots=P3YA5fkwRF%26sig=jdOGGfHQvwB35IbZJCtSDSPVq5A."},{"issue":"December","key":"4387_CR6","doi-asserted-by":"publisher","first-page":"1053559","DOI":"10.3389\/fgene.2022.1053559","volume":"13","author":"R Giugliani","year":"2022","unstructured":"Giugliani R, Taucher SC, Hafez S, Oliveira JB, Rico-Restrepo M, Rozenfeld P, et al. Opportunities and challenges for Newborn screening and early diagnosis of Rare Diseases in Latin America. Front Genet. 2022;13(December):1053559. https:\/\/doi.org\/10.3389\/fgene.2022.1053559.","journal-title":"Front Genet"},{"key":"4387_CR7","doi-asserted-by":"publisher","first-page":"1127713","DOI":"10.3389\/fpubh.2023.1127713","volume":"11","author":"AG Dias","year":"2023","unstructured":"Dias AG, Daher A, Ortiz LB, Carre\u00f1o-Moreno S, Hafez H SR, Jansen AM, et al. Rarecare: a policy Perspective on the burden of Rare Diseases on caregivers in Latin America. Front Public Health. 2023, March;11:1127713. https:\/\/doi.org\/10.3389\/fpubh.2023.1127713.","journal-title":"Front Public Health"},{"issue":"1","key":"4387_CR8","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/s13023-019-1261-8","volume":"14","author":"G Encina","year":"2019","unstructured":"Encina G, Castillo-Laborde C, Lecaros JA, Dubois-Camacho K, Calder\u00f3n JF, Aguilera X, et al. Rare Diseases in Chile: challenges and recommendations in universal health coverage context. Orphanet J Rare Dis. 2019;14(1):289. https:\/\/doi.org\/10.1186\/s13023-019-1261-8.","journal-title":"Orphanet J Rare Dis"},{"issue":"100434","key":"4387_CR9","doi-asserted-by":"publisher","first-page":"100434","DOI":"10.1016\/j.lana.2023.100434","volume":"18","author":"D Wainstock","year":"2023","unstructured":"Wainstock D, Katz A. Advancing Rare disease Policy in Latin America: a call to action. Lancet Reg Health Am. 2023;18(100434):100434. https:\/\/doi.org\/10.1016\/j.lana.2023.100434.","journal-title":"LancetThe Lancet Reg Health - Americas"},{"issue":"1","key":"4387_CR10","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1186\/s13023-022-02358-x","volume":"17","author":"A Bauskis","year":"2022","unstructured":"Bauskis A, Strange C, Molster C, Fisher C. The diagnostic odyssey: insights from parents of children living with an Undiagnosed condition. Orphanet J Rare Dis. 2022;17(1):233. https:\/\/doi.org\/10.1186\/s13023-022-02358-x.","journal-title":"Orphanet J Rare Dis"},{"key":"4387_CR11","unstructured":"Hobbs K. Accurate diagnosis of Rare Diseases remains difficult despite strong physician interest. Global genes. 2014 February 20. https:\/\/globalgenes.org\/blog\/accurate-diagnosis-of-rare-diseases-remains-difficult-despite-strong-physician-interest-2\/."},{"issue":"1","key":"4387_CR12","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13073-022-01026-w","volume":"14","author":"S Marwaha","year":"2022","unstructured":"Marwaha S, Knowles JW, Ashley EA. A guide for the diagnosis of Rare and Undiagnosed disease: beyond the exome. Genome Med. 2022;14(1):23. https:\/\/doi.org\/10.1186\/s13073-022-01026-w.","journal-title":"Genome Med"},{"issue":"1","key":"4387_CR13","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1186\/s13023-024-03319-2","volume":"19","author":"C Phillips","year":"2024","unstructured":"Phillips C, Parkinson A, Namsrai T, Chalmers A, Dews C, Gregory D, et al. Time to diagnosis for a Rare disease: managing medical uncertainty. A qualitative study. Orphanet J Rare Dis. 2024;19(1):297. https:\/\/doi.org\/10.1186\/s13023-024-03319-2.","journal-title":"Orphanet J Rare Dis"},{"issue":"10","key":"4387_CR14","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1038\/s41431-024-01609-8","volume":"32","author":"HM Velasco","year":"2024","unstructured":"Velasco HM, Bertoli-Avella A, Jaramillo CJ, Cardona DS, Gonz\u00e1lez LA, Vanegas MN, et al. Facing the challenges to shorten the diagnostic odyssey: first Whole Genome sequencing experience of a Colombian cohort with suspected rare diseases. Eur J Hum Genet. 2024;32(10):1327\u201337. https:\/\/doi.org\/10.1038\/s41431-024-01609-8.","journal-title":"Eur J Hum Genet"},{"issue":"9","key":"4387_CR15","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/gb-2011-12-9-228","volume":"12","author":"C Gilissen","year":"2011","unstructured":"Gilissen C, Hoischen A, Brunner HG, Veltman JA. Unlocking Mendelian disease using exome sequencing. Genome Biol. 2011;12(9):228. https:\/\/doi.org\/10.1186\/gb-2011-12-9-228.","journal-title":"Genome Biol"},{"issue":"1","key":"4387_CR16","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41525-020-00144-x","volume":"5","author":"JLF Fung","year":"2020","unstructured":"Fung JLF, Yu MHC, Huang S, Chung CCY, Chan MCY, Pajusalu S, et al. A three-year follow-up study evaluating clinical utility of exome sequencing and diagnostic potential of reanalysis. NPJ Genom Med. 2020;5(1):37. https:\/\/doi.org\/10.1038\/s41525-020-00144-x.","journal-title":"npj Genom Med"},{"issue":"1","key":"4387_CR17","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41525-024-00396-x","volume":"9","author":"KM Wigby","year":"2024","unstructured":"Wigby KM, Brockman D, Costain G, Hale C, Taylor SL, Belmont J, et al. Evidence Review and considerations for use of first line Genome sequencing to diagnose rare genetic disorders. NPJ Genom Med. 2024;9(1):15. https:\/\/doi.org\/10.1038\/s41525-024-00396-x.","journal-title":"npj Genom Med"},{"issue":"1","key":"4387_CR18","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.cell.2019.02.032","volume":"177","author":"T Lappalainen","year":"2019","unstructured":"Lappalainen T, Scott AJ, Brandt M, Hall IM. Genomic analysis in the age of Human Genome sequencing. Cell. 2019;177(1):70\u201384. https:\/\/doi.org\/10.1016\/j.cell.2019.02.032.","journal-title":"Cell"},{"issue":"7814","key":"4387_CR19","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41586-020-2434-2","volume":"583","author":"E Turro","year":"2020","unstructured":"Turro E, Astle WJ, Megy K, Gr\u00e4f S, Greene D, Shamardina O, et al. Whole-Genome sequencing of patients with rare Diseases in a national Health system. Nature. 2020;583(7814):96\u2013102. https:\/\/doi.org\/10.1038\/s41586-020-2434-2.","journal-title":"Nature"},{"issue":"8","key":"4387_CR20","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1016\/j.ajhg.2023.06.009","volume":"110","author":"MH Wojcik","year":"2023","unstructured":"Wojcik MH, Reuter CM, Marwaha S, Mahmoud M, Duyzend MH, Barseghyan H, et al. Beyond the exome: What\u2019s next in diagnostic testing for Mendelian conditions. Am J Hum Genet. 2023;110(8):1229\u201348. https:\/\/doi.org\/10.1016\/j.ajhg.2023.06.009.","journal-title":"Am J Hum Genet"},{"issue":"4","key":"4387_CR21","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1101\/gr.279970.124","volume":"35","author":"G Del","year":"2025","unstructured":"Del G, Boycott KM. The additional diagnostic yield of long-read sequencing in Undiagnosed Rare Diseases. Genome Res. 2025;35(4):559\u201371. https:\/\/doi.org\/10.1101\/gr.279970.124.","journal-title":"Genome Res"},{"issue":"10","key":"4387_CR22","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1038\/s41431-022-01162-2","volume":"30","author":"LJ Ewans","year":"2022","unstructured":"Ewans LJ, Minoche AE, Schofield D, Shrestha R, Puttick C, Zhu Y, et al. Whole exome and Genome sequencing in Mendelian disorders: a diagnostic and Health economic analysis. Eur J Hum Genet. 2022;30(10):1121\u201331. https:\/\/doi.org\/10.1038\/s41431-022-01162-2.","journal-title":"Eur J Hum Genet"},{"issue":"1","key":"4387_CR23","doi-asserted-by":"publisher","first-page":"136","DOI":"10.3390\/genes15010136","volume":"15","author":"J Park","year":"2024","unstructured":"Park J, Sturm M, Seibel-Kelemen O, Ossowski S, Haack TB. Lessons learned from translating Genome sequencing to clinical routine: understanding the accuracy of a diagnostic pipeline. Genes. 2024;15(1):136. https:\/\/doi.org\/10.3390\/genes15010136.","journal-title":"Genes"},{"key":"4387_CR24","doi-asserted-by":"publisher","unstructured":"C\u00f3rdoba M, Rodriguez-Quiroga SA, Vega PA, Salinas V, Perez-Maturo J, Amartino H, et al. Whole exome sequencing in neurogenetic odysseys: an effective, cost- and time-saving diagnostic approach. PLoS One. 2018;13(2):e0191228. https:\/\/doi.org\/10.1371\/journal.pone.0191228.","DOI":"10.1371\/journal.pone.0191228"},{"issue":"6","key":"4387_CR25","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1038\/s41436-020-0771-z","volume":"22","author":"J Malinowski","year":"2020","unstructured":"Malinowski J, Miller DT, Demmer L, Gannon J, Pereira EM, Schroeder MC, et al. Systematic Evidence-based review: outcomes from exome and genome sequencing for pediatric patients with Congenital Anomalies or Intellectual Disability. Genet Med: Off J Am Coll Med Genet. 2020;22(6):986\u20131004. https:\/\/doi.org\/10.1038\/s41436-020-0771-z.","journal-title":"Genet Med: Off J The Am Coll Med Genet"},{"issue":"11","key":"4387_CR26","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1038\/s41436-021-01242-6","volume":"23","author":"K Manickam","year":"2021","unstructured":"Manickam K, McClain MR, Demmer LA, Biswas S, Kearney HM, Malinowski J, et al. Exome and Genome sequencing for pediatric patients with congenital Anomalies or Intellectual Disability: an Evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG). Genet Med: Off J The Am Coll Med Genet. 2021;23(11):2029\u201337. https:\/\/doi.org\/10.1038\/s41436-021-01242-6.","journal-title":"Genet Med: Off J The Am Coll Med Genet"},{"key":"4387_CR27","doi-asserted-by":"publisher","unstructured":"Stark Z, Dolman L, Manolio TA, Ozenberger B, Hill SL, Caulfied MJ, et al. Integrating Genomics into healthcare: a global responsibility. Am J Hum Genet. 2019a;104(1):13\u201320. https:\/\/doi.org\/10.1016\/j.ajhg.2018.11.014","DOI":"10.1016\/j.ajhg.2018.11.014"},{"issue":"1","key":"4387_CR28","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41525-024-00434-8","volume":"9","author":"J Bazalar-Montoya","year":"2024","unstructured":"Bazalar-Montoya J, Cornejo-Olivas M, Duenas-Roque MM, Purizaca-Rosillo N, Rodriguez RS, Milla-Neyra K, et al. Clinical Genome sequencing in patients with suspected Rare genetic disease in Peru. NPJ Genom Med. 2024;9(1):51. https:\/\/doi.org\/10.1038\/s41525-024-00434-8.","journal-title":"npj Genom Med"},{"issue":"1","key":"4387_CR29","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13023-019-1291-2","volume":"15","author":"JA Bevilacqua","year":"2020","unstructured":"Bevilacqua JA, Ehuletche MDR, Perna A, Dubrovsky A, Franca MC, Vargas S, et al. The Latin American experience with a next generation sequencing genetic panel for recessive limb-girdle muscular weakness and pompe disease. Orphanet J Rare Dis. 2020;15(1):11. https:\/\/doi.org\/10.1186\/s13023-019-1291-2.","journal-title":"Orphanet J Rare Dis"},{"issue":"821582","key":"4387_CR30","doi-asserted-by":"publisher","first-page":"821582","DOI":"10.3389\/fmolb.2022.821582","volume":"9","author":"AVC Coelho","year":"2022","unstructured":"Coelho AVC, Mascaro-Cordeiro B, Lucon DR, N\u00f3brega MS, Reis RDS, de Alexandre RB, et al. The Brazilian Rare Genomes Project: validation of Whole Genome sequencing for Rare Diseases diagnosis. Front Mol Biosci. 2022;9(821582):821582. https:\/\/doi.org\/10.3389\/fmolb.2022.821582.","journal-title":"Front Mol Biosci"},{"issue":"1","key":"4387_CR31","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12939-022-01809-y","volume":"22","author":"TM F\u00e9lix","year":"2023","unstructured":"F\u00e9lix TM, de Souza CFM, Oliveira JB, Rico-Restrepo M, Zanoteli E, Zatz M, et al. Challenges and Recommendations to increasing the use of exome sequencing and Whole Genome sequencing for diagnosing Rare Diseases in Brazil: an expert Perspective. Int J Equity Health. 2023;22(1):11. https:\/\/doi.org\/10.1186\/s12939-022-01809-y.","journal-title":"Int J Equity Health"},{"issue":"3","key":"4387_CR32","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/ejhg.2014.107","volume":"23","author":"C Gonzaga-Jauregui","year":"2015","unstructured":"Gonzaga-Jauregui C, Gamble CN, Yuan B, Penney S, Jhangiani S, Muzny DM, et al. Mutations in COL27A1 Cause steel syndrome and suggest a Founder Mutation effect in the Puerto Rican population. Eur J Hum Genet. 2015;23(3):342\u201346. https:\/\/doi.org\/10.1038\/ejhg.2014.107.","journal-title":"Eur J Hum Genet"},{"issue":"9","key":"4387_CR33","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1038\/s41431-020-0632-x","volume":"28","author":"C Gonzaga-Jauregui","year":"2020","unstructured":"Gonzaga-Jauregui C, Yesil G, Nistala H, Gezdirici A, Bayram Y, Nannuru KC, et al. Functional biology of the steel syndrome founder allele and evidence for clan genomics derivation of COL27A1 pathogenic alleles worldwide. Eur J Hum Genet. 2020;28(9):1243\u201364. https:\/\/doi.org\/10.1038\/s41431-020-0632-x.","journal-title":"Eur J Hum Genet"},{"issue":"10","key":"4387_CR34","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1038\/s41431-023-01523-5","volume":"32","author":"MC Poli","year":"2024","unstructured":"Poli MC, Rebolledo-Jaramillo B, Lagos C, Orellana J, Moreno G, Mart\u00edn LM, et al. Decoding complex inherited phenotypes in rare disorders: the DECIPHERD initiative for rare undiagnosed diseases in Chile. Eur J Hum Genet. 2024;32(10):1227\u201337. https:\/\/doi.org\/10.1038\/s41431-023-01523-5.","journal-title":"Eur J Hum Genet"},{"issue":"4","key":"4387_CR35","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1002\/ajmg.c.31860","volume":"184","author":"CRDC Quaio","year":"2020","unstructured":"Quaio CRDC, Moreira CM, Novo-Filho GM, Sacramento-Bobotis PR, Groenner Penna M, Perazzio SF, et al. Diagnostic power and clinical impact of exome sequencing in a cohort of 500 patients with rare diseases. Am J Med Genet Pt C. 2020;184(4):955\u201364. https:\/\/doi.org\/10.1002\/ajmg.c.31860.","journal-title":"Am J Med Genet Pt C"},{"issue":"1","key":"4387_CR36","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41525-018-0076-1","volume":"4","author":"A Scocchia","year":"2019","unstructured":"Scocchia A, Wigby KM, Masser-Frye D, Del Campo M, Galarreta CI, Thorpe E, et al. Clinical Whole genome sequencing as a first-tier test at a resource-limited dysmorphology clinic in mexico. NPJ Evidence Med. 2019;4(1):5. https:\/\/doi.org\/10.1038\/s41525-018-0076-1.","journal-title":"NPJ Evidence Med"},{"key":"4387_CR37","unstructured":"Metreau E, Young KE, Eapen SG. World Bank country classifications by income level for 2024-2025 [Internet]. World Bank Blogs. World Bank Group; 2025 [cited 2025 Dec 9]. https:\/\/blogs.worldbank.org\/en\/opendata\/world-bank-country-classifications-by-income-level-for-2024-2025."},{"issue":"1","key":"4387_CR38","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1146\/annurev-genom-111224-100329","volume":"26","author":"I Lopes-Cendes","year":"2025","unstructured":"Lopes-Cendes I, de Oliveira TC. Inequalities and inclusion in Genomics applied to healthcare: a Latin American perspective. Annu Rev Genomics Hum Genet. 2025;26(1):473\u201378. https:\/\/doi.org\/10.1146\/annurev-genom-111224-100329.","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"4387_CR39","unstructured":"Ministerio de Salud P\u00fablica. Plan Integral de Atenci\u00f3n en Salud (PIAS). n.d. December 8. https:\/\/www.gub.uy\/ministerio-salud-publica\/politicas-y-gestion\/plan-integral-atencion-salud-pias."},{"issue":"11","key":"4387_CR40","doi-asserted-by":"publisher","first-page":"100692","DOI":"10.1016\/j.xgen.2024.100692","volume":"4","author":"V Borda","year":"2024","unstructured":"Borda V, Loesch DP, Guo B, Laboulaye R, Veliz-Otani D, French JN, et al. Genetics of Latin American diversity project: insights into population genetics and association studies in admixed groups in the Americas. Cell Genomics. 2024;4(11):100692. https:\/\/doi.org\/10.1016\/j.xgen.2024.100692.","journal-title":"Cell Genomics"},{"issue":"7809","key":"4387_CR41","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","volume":"581","author":"KJ Karczewski","year":"2020","unstructured":"Karczewski KJ, Francioli LC, Tiao G, Cummings BB, Alf\u00f6ldi J, Wang Q, et al. The mutational constraint spectrum quantified from variation in 141, 456 humans. Nature. 2020;581(7809):434\u201343. https:\/\/doi.org\/10.1038\/s41586-020-2308-7.","journal-title":"Nature"},{"issue":"May","key":"4387_CR42","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.mito.2016.03.006","volume":"28","author":"L Spangenberg","year":"2016","unstructured":"Spangenberg L, Gra\u00f1a M, Greif G, Suarez-Rivero JM, Krysztal K, Tapi\u00e9 A, et al. 3697G>A in MT-ND1 is a causative mutation in mitochondrial disease. Mitochondrion. 2016;28(May):54\u201359. https:\/\/doi.org\/10.1016\/j.mito.2016.03.006.","journal-title":"Mitochondrion"},{"key":"4387_CR43","unstructured":"\u201cBabraham Bioinformatics - FastQC A Quality control tool for high throughput sequence data. n.d. December 9, 2025. https:\/\/www.bioinformatics.babraham.ac.uk\/projects\/fastqc\/."},{"issue":"14","key":"4387_CR44","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Durbin R. Fast and accurate short read alignment with Burrows\u2013Wheeler transform. Bioinf (Oxford, Engl). 2009;25(14):1754\u201360. https:\/\/doi.org\/10.1093\/bioinformatics\/btp324.","journal-title":"Bioinf (Oxford, Engl)"},{"key":"4387_CR45","unstructured":"Van der A, Geraldine, O\u2019Connor B. Genomics in the cloud. 2020."},{"key":"4387_CR46","doi-asserted-by":"publisher","unstructured":"Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-Throughput sequencing data. Nucleic Acids Res. 2010;38(16):e164. https:\/\/doi.org\/10.1093\/nar\/gkq603.","DOI":"10.1093\/nar\/gkq603"},{"issue":"8","key":"4387_CR47","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1093\/bioinformatics\/btv710","volume":"32","author":"X Chen","year":"2016","unstructured":"Chen X, Schulz-Trieglaff O, Shaw R, Barnes B, Schlesinger F, K\u00e4llberg M, et al. Manta: rapid detection of structural variants and indels for germline and Cancer sequencing applications. Bioinf (Oxford, Engl). 2016;32(8):1220\u201322. https:\/\/doi.org\/10.1093\/bioinformatics\/btv710.","journal-title":"Bioinf (Oxford, Engl)"},{"issue":"20","key":"4387_CR48","doi-asserted-by":"publisher","first-page":"3572","DOI":"10.1093\/bioinformatics\/bty304","volume":"34","author":"V Geoffroy","year":"2018","unstructured":"Geoffroy V, Herenger Y, Kress A, Stoetzel C, Piton A, Dollfus H, et al. AnnotSV: an integrated tool for structural variations annotation. Bioinf (Oxford, Engl. 2018;34(20):3572\u201374. https:\/\/doi.org\/10.1093\/bioinformatics\/bty304.","journal-title":"Bioinf (Oxford, Engl"},{"issue":"21","key":"4387_CR49","doi-asserted-by":"publisher","first-page":"3115","DOI":"10.1093\/bioinformatics\/btu483","volume":"30","author":"C Calabrese","year":"2014","unstructured":"Calabrese C, Simone D, Diroma MA, Santorsola M, Gutt\u00e0 C, Gasparre G, et al. MToolBox: a highly automated pipeline for heteroplasmy annotation and prioritization analysis of Human mitochondrial variants in high-Throughput sequencing. Bioinf (Oxford, Engl). 2014;30(21):3115\u201317. https:\/\/doi.org\/10.1093\/bioinformatics\/btu483.","journal-title":"Bioinf (Oxford, Engl)"},{"key":"4387_CR50","unstructured":"pbmm2: A minimap2 Frontend for PacBio Native Data Formats. Github. n.d. December 10, 2025. https:\/\/github.com\/PacificBiosciences\/pbmm2."},{"issue":"18","key":"4387_CR51","doi-asserted-by":"publisher","first-page":"3094","DOI":"10.1093\/bioinformatics\/bty191","volume":"34","author":"H Li","year":"2018","unstructured":"Li H. Minimap2: pairwise alignment for nucleotide sequences. Bioinf (Oxford, Engl). 2018;34(18):3094\u2013100. https:\/\/doi.org\/10.1093\/bioinformatics\/bty191.","journal-title":"Bioinf (Oxford, Engl)"},{"key":"4387_CR52","unstructured":"Pbsv: Pbsv - PacBio structural variant (SV) calling and analysis tools. Github. n.d. December 10, 2025. https:\/\/github.com\/PacificBiosciences\/pbsv."},{"key":"4387_CR53","doi-asserted-by":"publisher","unstructured":"Hu J, Ng PC. SIFT Indel: predictions for the functional effects of amino acid Insertions\/deletions in proteins. PLoS One. 2013;8(10):e77940. https:\/\/doi.org\/10.1371\/journal.pone.0077940.","DOI":"10.1371\/journal.pone.0077940"},{"issue":"3","key":"4387_CR54","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1086\/519795","volume":"81","author":"S Purcell","year":"2007","unstructured":"Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MAR, Bender D, et al. PLINK: a Tool Set for Whole-Genome association and population-based linkage analyses. Am J Hum Genet. 2007;81(3):559\u201375. https:\/\/doi.org\/10.1086\/519795.","journal-title":"Am J Hum Genet"},{"key":"4387_CR55","doi-asserted-by":"publisher","unstructured":"Webb B, Sali A. \u201cComparative protein structure modeling using MODELLER.\u201d Current protocols in Bioinformatics\/Editoral board, Andreas D. CP Bioinf. 2016;54(1):.5.6.1\u20135.6.37. https:\/\/doi.org\/10.1002\/cpbi.3.","DOI":"10.1002\/cpbi.3"},{"issue":"7873","key":"4387_CR56","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","volume":"596","author":"J Jumper","year":"2021","unstructured":"Jumper J, Evans R, Pritzel A, Green T, Figurnov M, Ronneberger O, et al. Highly accurate protein structure prediction with AlphaFold. Nature. 2021;596(7873):583\u201389. https:\/\/doi.org\/10.1038\/s41586-021-03819-2.","journal-title":"Nature"},{"issue":"1","key":"4387_CR57","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1186\/s12887-022-03595-6","volume":"22","author":"C Simoes","year":"2022","unstructured":"Simoes C, Gra\u00f1a M, Rodriguez S, Baltar Yanes F, Tapi\u00e9 A, Dell\u2019oca N, et al. Novel frameshift Mutation in LIS1 gene is a probable cause of lissencephaly: a case Report. BMC Pediatrics. 2022;22(1):545. https:\/\/doi.org\/10.1186\/s12887-022-03595-6.","journal-title":"BMC Pediatrics"},{"key":"4387_CR58","unstructured":"Team, R. D. C. R: a language and environment for statistical computing. (No title). 2010. https:\/\/cir.nii.ac.jp\/crid\/1370294721063650048."},{"issue":"1","key":"4387_CR59","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nbt.1754","volume":"29","author":"JT Robinson","year":"2011","unstructured":"Robinson JT, Thorvaldsd\u00f3ttir H, Winckler W, Guttman M, Lander ES, Getz G, et al. Integrative genomics viewer. Nat Biotechnol. 2011;29(1):24\u201326. https:\/\/doi.org\/10.1038\/nbt.1754.","journal-title":"Nat Biotechnol"},{"issue":"2","key":"4387_CR60","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1093\/bib\/bbs017","volume":"14","author":"H Thorvaldsd\u00f3ttir","year":"2013","unstructured":"Thorvaldsd\u00f3ttir H, Robinson JT, Mesirov JP. Integrative Genomics Viewer (IGV): High-performance Genomics data visualization and exploration. Briefings Bioinf. 2013;14(2):178\u201392. https:\/\/doi.org\/10.1093\/bib\/bbs017.","journal-title":"Briefings Bioinf"},{"key":"4387_CR61","doi-asserted-by":"publisher","unstructured":"Robinson JT, Thorvaldsd\u00f3ttir H, Wenger AM, Zehir A, Mesirov JP. Variant Review with the Integrative Genomics Viewer. Cancer Res. 2017;77(21):e31\u201334. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-0337.","DOI":"10.1158\/0008-5472.CAN-17-0337"},{"key":"4387_CR62","doi-asserted-by":"publisher","unstructured":"Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, Fennell T, et al. Analysis of protein-coding genetic variation in 60,706 humans. Nat. 2016;536(7616):285\u201391. https:\/\/doi.org\/10.1038\/nature19057.","DOI":"10.1038\/nature19057"},{"key":"4387_CR63","doi-asserted-by":"publisher","unstructured":"Auton A, Abecasis GR, Altshuler DM, Durbin RM, Bentley DR, Chakravarti A, et al. A global reference for human genetic variation. Nat. 2015;526(7571):68\u201374. https:\/\/doi.org\/10.1038\/nature15393.","DOI":"10.1038\/nature15393"},{"key":"4387_CR64","unstructured":"Online Mendelian Inheritance in Man, OMIM\u00ae. Johns Hopkins University, Baltimore, MD. Available from: https:\/\/omim.org\/."},{"key":"4387_CR65","doi-asserted-by":"publisher","unstructured":"Gargano MA, Matentzoglu N, Coleman B, Addo-Lartey EB, Anagnostopoulos AV, Anderton J, et al. The Human Phenotype Ontology in 2024: phenotypes around the world. Nucleic Acids Res. 2024;52(D1):D1333\u201346. https:\/\/doi.org\/10.1093\/nar\/gkad100.","DOI":"10.1093\/nar\/gkad100"},{"issue":"2","key":"4387_CR66","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/gim.2016.190","volume":"19","author":"SS Kalia","year":"2017","unstructured":"Kalia SS, Adelman K, Bale SJ, Chung WK, Eng C, Evans JP, et al. Recommendations for Reporting of Secondary findings in clinical exome and Genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American college of medical genetics and genomics. Genet Med: Off J The Am Coll Med Genet. 2017;19(2):249\u201355. https:\/\/doi.org\/10.1038\/gim.2016.190.","journal-title":"Genet Med: Off J The Am Coll Med Genet"},{"issue":"8","key":"4387_CR67","doi-asserted-by":"publisher","first-page":"101454","DOI":"10.1016\/j.gim.2025.101454","volume":"27","author":"K Lee","year":"2025","unstructured":"Lee K, Abul-Husn NS, Amendola LM, Brothers KB, Chung WK, Gollob MH, et al. ACMG SF v3.3 list for Reporting of Secondary findings in clinical exome and Genome sequencing: a Policy Statement of the American College of Medical Genetics and Genomics (ACMG). Genet Med: Off J The Am Coll Med Genet. 2025;27(8):101454. https:\/\/doi.org\/10.1016\/j.gim.2025.101454.","journal-title":"Genet Med: Off J The Am Coll Med Genet"},{"issue":"7","key":"4387_CR68","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1016\/j.gim.2022.04.006","volume":"24","author":"DT Miller","year":"2022","unstructured":"Miller DT, Lee K, Abul-Husn NS, Amendola LM, Brothers K, Chung WK, et al. ACMG SF v3.1 list for Reporting of Secondary findings in clinical exome and genome sequencing: a policy statement of the American college of medical genetics and genomics (ACMG). Genet Med: Off J The Am Coll Med Genet. 2022;24(7):1407\u201314. https:\/\/doi.org\/10.1016\/j.gim.2022.04.006.","journal-title":"Genet Med: Off J The Am Coll Med Genet"},{"issue":"8","key":"4387_CR69","doi-asserted-by":"publisher","first-page":"100866","DOI":"10.1016\/j.gim.2023.100866","volume":"25","author":"DT Miller","year":"2023","unstructured":"Miller DT, Lee K, Abul-Husn NS, Amendola LM, Brothers K, Chung WK, et al. ACMG SF v3.2 list for Reporting of Secondary findings in clinical exome and genome sequencing: a policy statement of the American college of medical genetics and genomics (ACMG). Genet Med: Off J The Am Coll Med Genet. 2023;25(8):100866. https:\/\/doi.org\/10.1016\/j.gim.2023.100866.","journal-title":"Genet Med: Off J The Am Coll Med Genet"},{"issue":"8","key":"4387_CR70","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1038\/s41436-021-01172-3","volume":"23","author":"DT Miller","year":"2021","unstructured":"Miller DT, Lee K, Chung WK, Gordon AS, Herman GE, Klein TE, et al. ACMG SF v3.0 list for Reporting of Secondary findings in clinical exome and genome sequencing: a policy statement of the American college of medical genetics and genomics (ACMG). Genet Med: Off J The Am Coll Med Genet. 2021;23(8):1381\u201390. https:\/\/doi.org\/10.1038\/s41436-021-01172-3.","journal-title":"Genet Med: Off J The Am Coll Med Genet"},{"key":"4387_CR71","doi-asserted-by":"publisher","unstructured":"Ng PC, Henikoff S. SIFT: Predicting amino acid changes that affect protein function. Nucleic Acids Res. 2003;31(13):3812\u20134. https:\/\/doi.org\/10.1093\/nar\/gkg509.","DOI":"10.1093\/nar\/gkg509"},{"key":"4387_CR72","doi-asserted-by":"publisher","unstructured":"Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, et al. A method and server for predicting damaging missense mutations. Nat Methods. 2010;7(4):248\u20139. https:\/\/doi.org\/10.1038\/nmeth0410-24.","DOI":"10.1038\/nmeth0410-24"},{"key":"4387_CR73","doi-asserted-by":"publisher","unstructured":"Schwarz JM, Cooper DN, Schuelke M, Seelow D. MutationTaster2: mutation prediction for the deep-sequencing age. Nat Methods. 2014;11(4):361\u20132. https:\/\/doi.org\/10.1038\/nmeth.2890.","DOI":"10.1038\/nmeth.2890"},{"key":"4387_CR74","doi-asserted-by":"publisher","unstructured":"Choi Y, Chan AP. PROVEAN web server: a tool to predict the functional effect of amino acid substitutions and indels. Bioinformatics. 2015;31(16):2745\u20137. https:\/\/doi.org\/10.1093\/bioinformatics\/btv195.","DOI":"10.1093\/bioinformatics\/btv195"},{"key":"4387_CR75","doi-asserted-by":"publisher","unstructured":"Ioannidis NM, Rothstein JH, Pejaver V, Middha S, McDonnell SK, Baheti S, et al. REVEL: An ensemble method for predicting the pathogenicity of rare missense variants. Am J Hum Genet. 2016;99(4):877\u201385. https:\/\/doi.org\/10.1016\/j.ajhg.2016.08.016.","DOI":"10.1016\/j.ajhg.2016.08.016"},{"key":"4387_CR76","doi-asserted-by":"publisher","unstructured":"Rentzsch P, Witten D, Cooper GM, Shendure J, Kircher M. CADD: predicting the deleteriousness of variants throughout the human genome. Nucleic Acids Res. 2019;47(D1):D886\u201394. https:\/\/doi.org\/10.1093\/nar\/gky1016.","DOI":"10.1093\/nar\/gky1016"},{"key":"4387_CR77","doi-asserted-by":"publisher","unstructured":"Dong C, Wei P, Jian X, Gibbs R, Boerwinkle E, Wang K, et al. Comparison and integration of deleteriousness prediction methods for nonsynonymous SNVs in whole exome sequencing studies. Hum Mol Genet. 2015;24(8):2125\u201337. https:\/\/doi.org\/10.1093\/hmg\/ddu733.","DOI":"10.1093\/hmg\/ddu733"},{"key":"4387_CR78","doi-asserted-by":"publisher","unstructured":"Davydov EV, Goode DL, Sirota M, Cooper GM, Sidow A, Batzoglou S. Identifying a high fraction of the human genome to be under selective constraint using GERP++. PLoS Comput Biol. 2010;6(12):e1001025. https:\/\/doi.org\/10.1371\/journal.pcbi.1001025.","DOI":"10.1371\/journal.pcbi.1001025"},{"key":"4387_CR79","doi-asserted-by":"publisher","unstructured":"Cooper GM, Stone EA, Asimenos G, NISC Comparative Sequencing Program, Green ED, Batzoglou S, et al. Distribution and intensity of constraint in mammalian genomic sequence. Genome Res. 2005;15(7):901\u201313. https:\/\/doi.org\/10.1101\/gr.3577405.","DOI":"10.1101\/gr.3577405"},{"key":"4387_CR80","doi-asserted-by":"publisher","unstructured":"Siepel A, Bejerano G, Pedersen JS, Hinrichs AS, Hou M, Rosenbloom K, et al. Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes. Genome Res. 2005;15(8):1034\u201350. https:\/\/doi.org\/10.1101\/gr.3715005.","DOI":"10.1101\/gr.3715005"},{"key":"4387_CR81","doi-asserted-by":"publisher","unstructured":"Jaganathan K, Kyriazopoulou Panagiotopoulou S, McRae JF, Darbandi SF, Knowles D, Li YI, et al. Predicting splicing from primary sequence with deep learning. Cell. 2019;176(3):535\u201348.e24. https:\/\/doi.org\/10.1016\/j.cell.2018.12.015.","DOI":"10.1016\/j.cell.2018.12.015"},{"key":"4387_CR82","doi-asserted-by":"publisher","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405\u201324. https:\/\/doi.org\/10.1038\/gim.2015.30.","DOI":"10.1038\/gim.2015.30"},{"key":"4387_CR83","doi-asserted-by":"publisher","unstructured":"Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, et al. Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria. Genet Med. 2017;19(10):1105\u201317. https:\/\/doi.org\/10.1038\/gim.2017.37.","DOI":"10.1038\/gim.2017.37"},{"key":"4387_CR84","doi-asserted-by":"publisher","unstructured":"Landrum MJ, Lee JM, Riley GR, Jang W, Rubinstein WS, Church DM, et al. ClinVar: public archive of relationships among sequence variation and human phenotype. Nucleic Acids Res. 2014;42(Database issue):D980\u20135. https:\/\/doi.org\/10.1093\/nar\/gkt1113.","DOI":"10.1093\/nar\/gkt1113"},{"issue":"2","key":"4387_CR85","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/cge.12569","volume":"89","author":"V Shashi","year":"2016","unstructured":"Shashi V, McConkie-Rosell A, Schoch K, Kasturi V, Rehder C, Jiang YH, et al. Practical Considerations in the clinical application of Whole-exome sequencing. Clin Genet. 2016;89(2):173\u201381. https:\/\/doi.org\/10.1111\/cge.12569.","journal-title":"Clin Genet"},{"issue":"May","key":"4387_CR86","doi-asserted-by":"publisher","first-page":"1379254","DOI":"10.3389\/fped.2024.1379254","volume":"12","author":"F Baltar","year":"2024","unstructured":"Baltar F, Simoes C, Garagorry F, Gra\u00f1a M, Rodr\u00edguez S, Hayd\u00e9e Aunchayna M, et al. Two compound heterozygous variants in the CLN8 gene are responsible for neuronal cereidolipofuscinoses disorder in a child: a case Report. Front. Pediatr. 2024;12(May):1379254. https:\/\/doi.org\/10.3389\/fped.2024.1379254.","journal-title":"Front. Pediatr"},{"key":"4387_CR87","doi-asserted-by":"publisher","unstructured":"Spangenberg MN, Grille S, Simoes C, Dell\u2019Oca N, Boada M, Guillermo C, et al. Two mutations in the SBDS gene reveal a diagnosis of shwachman\u2013diamond syndrome in a patient with atypical symptoms. Cold Spring Harb Mol Case Stud. 2022;8(7):a006237. https:\/\/doi.org\/10.1101\/mcs.a006237.","DOI":"10.1101\/mcs.a006237"},{"issue":"September","key":"4387_CR88","doi-asserted-by":"publisher","first-page":"1248964","DOI":"10.3389\/fonc.2023.1248964","volume":"13","author":"MN Spangenberg","year":"2023","unstructured":"Spangenberg MN, Grille S, Simoes C, Brandes M, Garcia-Luna J, Catal\u00e1n AI, et al. Case Report: mycosis fungoides as an exclusive manifestation of common variable immunodeficiency in a family with a NFKB2 gene Mutation. Front Oncol. 2023;13(September):1248964. https:\/\/doi.org\/10.3389\/fonc.2023.1248964.","journal-title":"Front Oncol"},{"key":"4387_CR89","unstructured":"Barreto I, Sans M. Endogamia y consanguinidad en la poblaci\u00f3n uruguaya: los inmigrantes y sus pautas matrimoniales. Investigaciones en biodiversidad humana. 2000;28\u201334."},{"key":"4387_CR90","doi-asserted-by":"publisher","unstructured":"Spangenberg L, Fariello MI, Arce D, Illanes G, Greif G, Shin J-Y, et al. Indigenous ancestry and admixture in the Uruguayan population. Front Genet. 2021a;12(September):733195. https:\/\/doi.org\/10.3389\/fgene.2021.733195","DOI":"10.3389\/fgene.2021.733195"},{"issue":"1","key":"4387_CR91","doi-asserted-by":"publisher","first-page":"1","DOI":"10.24215\/18536387e029","volume":"23","author":"M Sans","year":"2021","unstructured":"Sans M, Figueiro G, Bonilla C, Bertoni B, Cappetta M, Artagaveytia N, et al. Ancestr\u00eda gen\u00e9tica y estratificaci\u00f3n social en Montevideo, Uruguay. RevArgAntropBiol. 2021;23(1):1\u201319. https:\/\/doi.org\/10.24215\/18536387e029","journal-title":"RevArgAntropBiol"},{"key":"4387_CR92","unstructured":"Mussio I, Triunfo P, Gerstenbl\u00fcth M, Raggio V, Cardozo P, Naya H, et al. From the Rare to the essential: analyzing the needs of physicians and families Managing Rare Diseases. Under Rev. n.d."},{"issue":"1","key":"4387_CR93","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s40246-021-00328-1","volume":"15","author":"V Raggio","year":"2021","unstructured":"Raggio V, Dell\u2019oca N, Simoes C, Tapi\u00e9 A, Medici C, Costa G, et al. Whole Genome sequencing reveals a frameshift Mutation and a large deletion in YY1AP1 in a girl with a panvascular artery disease. Hum Genomics. 2021;15(1):28. https:\/\/doi.org\/10.1186\/s40246-021-00328-1.","journal-title":"Hum Genomics"},{"issue":"1","key":"4387_CR94","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40246-023-00463-x","volume":"17","author":"V Raggio","year":"2023","unstructured":"Raggio V, Gra\u00f1a M, Winiarski E, Mansilla S, Simoes C, Rodr\u00edguez S, et al. Computational and mitochondrial functional studies of Novel compound heterozygous variants in SPATA5 gene support a causal link with epileptogenic Encephalopathy. Hum Genomics. 2023;17(1):14. https:\/\/doi.org\/10.1186\/s40246-023-00463-x.","journal-title":"Hum Genomics"},{"issue":"1","key":"4387_CR95","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1186\/s13256-025-05480-z","volume":"19","author":"V Raggio","year":"2025","unstructured":"Raggio V, Rey A, Simoes C, Birriel F, Rodriguez S, Bentancor K, et al. Identification of a Novel SACS gene Mutation leading to spastic ataxia charlevoix-saguenay type: a case Report. J Med Case Rep. 2025;19(1):412. https:\/\/doi.org\/10.1186\/s13256-025-05480-z.","journal-title":"J Med Case Rep"},{"key":"4387_CR96","doi-asserted-by":"publisher","unstructured":"Spangenberg L, Guecaimbur\u00fa R, Tapi\u00e9 A, Vivas S, Rodr\u00edguez S, Gra\u00f1a M, et al. Novel frameshift Mutation in PURA gene causes severe Encephalopathy of unclear Cause. Molec Gen & Gen Med. 2021b;9(5):e 1622. https:\/\/doi.org\/10.1002\/mgg3.1622","DOI":"10.1002\/mgg3.1622"},{"issue":"1","key":"4387_CR97","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1002\/ajmg.a.62491","volume":"188","author":"T Aloraini","year":"2022","unstructured":"Aloraini T, Alsubaie L, Alasker S, Al Muitiri A, Alswaid A, Eyiad W, et al. The rate of Secondary genomic findings in the Saudi population. Am J Med Genet Pt A. 2022;188(1):83\u201388. https:\/\/doi.org\/10.1002\/ajmg.a.62491.","journal-title":"Am J Med Genet Pt A"},{"key":"4387_CR98","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3389\/fgene.2020.00208","volume":"11","author":"N Jalkh","year":"2020","unstructured":"Jalkh N, Mehawej C, Chouery E. Actionable exomic Secondary findings in 280 Lebanese participants. Front Genet. 2020, March;11:208. https:\/\/doi.org\/10.3389\/fgene.2020.00208.","journal-title":"Front Genet"},{"issue":"November","key":"4387_CR99","doi-asserted-by":"publisher","first-page":"956723","DOI":"10.3389\/fgene.2022.956723","volume":"13","author":"S Martone","year":"2022","unstructured":"Martone S, Buonagura AT, Marra R, Rosato BE, Del Giudice F, Bonfiglio F, et al. Clinical exome-based panel testing for medically actionable Secondary findings in a cohort of 383 Italian participants. Front Genet. 2022;13(November):956723. https:\/\/doi.org\/10.3389\/fgene.2022.956723.","journal-title":"Front Genet"},{"issue":"7","key":"4387_CR100","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.ajhg.2024.05.006","volume":"111","author":"E Thorpe","year":"2024","unstructured":"Thorpe E, Williams T, Shaw C, Chekalin E, Ortega J, Robinson K, et al. The impact of clinical Genome sequencing in a global population with suspected Rare genetic disease. Am J Hum Genet. 2024;111(7):1271\u201381. https:\/\/doi.org\/10.1016\/j.ajhg.2024.05.006.","journal-title":"Am J Hum Genet"},{"key":"4387_CR101","doi-asserted-by":"publisher","unstructured":"Stark Z, Schofield D, Martyn M, Rynehart L, Shrestha R, Alam K, et al. Does genomic sequencing early in the diagnostic trajectory make a difference? A follow-up study of clinical Outcomes and cost-effectiveness. Genet Med: Off J The Am Coll Med Genet. 2019b;21(1):173\u201380. https:\/\/doi.org\/10.1038\/s41436-018-0006-8","DOI":"10.1038\/s41436-018-0006-8"},{"issue":"11","key":"4387_CR102","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/s41576-023-00621-w","volume":"24","author":"Z Stark","year":"2023","unstructured":"Stark Z, Scott RH. Genomic Newborn Screening for Rare Diseases. Nat Rev Genet. 2023;24(11):755\u201366. https:\/\/doi.org\/10.1038\/s41576-023-00621-w.","journal-title":"Nat Rev Genet"},{"issue":"6","key":"4387_CR103","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/s41576-023-00683-w","volume":"25","author":"KD Kernohan","year":"2024","unstructured":"Kernohan KD, Boycott KM. The Expanding diagnostic toolbox for Rare genetic Diseases. Nat Rev Genet. 2024;25(6):401\u201315. https:\/\/doi.org\/10.1038\/s41576-023-00683-w.","journal-title":"Nat Rev Genet"},{"issue":"1","key":"4387_CR104","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s13023-020-01376-x","volume":"15","author":"K Kerr","year":"2020","unstructured":"Kerr K, McAneney H, Smyth LJ, Bailie C, McKee S, McKnight AJ. A scoping Review and proposed workflow for multi-Omic Rare disease research. Orphanet J Rare Dis. 2020;15(1):107. https:\/\/doi.org\/10.1186\/s13023-020-01376-x.","journal-title":"Orphanet J Rare Dis"},{"key":"4387_CR105","doi-asserted-by":"publisher","unstructured":"Kopajtich R, Smirnov D, Stenton SL, et al. Integration of proteomics with Genomics and transcriptomics increases the diagnostic rate of mendelian disorders. bioRxiv. MedRxiv. 2021, March, 12. https:\/\/doi.org\/10.1101\/2021.03.09.21253187.","DOI":"10.1101\/2021.03.09.21253187"},{"issue":"7","key":"4387_CR106","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1038\/s41591-023-02401-9","volume":"29","author":"S Lunke","year":"2023","unstructured":"Lunke S, Bouffler SE, Patel CV, Sandaradura SA, Wilson M, Pinner J, et al. Integrated multi-omics for Rapid Rare disease diagnosis on a national scale. Nat Med. 2023;29(7):1681\u201391. https:\/\/doi.org\/10.1038\/s41591-023-02401-9.","journal-title":"Nat Med"},{"issue":"1","key":"4387_CR107","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/s41525-022-00331-y","volume":"7","author":"S Miyatake","year":"2022","unstructured":"Miyatake S, Koshimizu E, Fujita A, Doi H, Okubo M, Wada T, et al. Rapid and comprehensive diagnostic method for repeat expansion Diseases using Nanopore sequencing. npj Genom Med. 2022;7(1):62. https:\/\/doi.org\/10.1038\/s41525-022-00331-y.","journal-title":"npj Genom Med"},{"key":"4387_CR108","doi-asserted-by":"publisher","first-page":"1374860","DOI":"10.3389\/fgene.2024.1374860","volume":"15","author":"G Olivucci","year":"2024","unstructured":"Olivucci G, Iovino E, Innella G, Turchetti D, Pippucci T, Magini P. Long read sequencing on its way to the routine diagnostics of genetic Diseases. Front Genet. 2024, March;15:1374860. https:\/\/doi.org\/10.3389\/fgene.2024.1374860.","journal-title":"Front Genet"},{"issue":"4","key":"4387_CR109","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1002\/jimd.12507","volume":"45","author":"SB Wortmann","year":"2022","unstructured":"Wortmann SB, Oud MM, Alders M, Coene KLM, van der Crabben SN, Feichtinger RG, et al. How to proceed after \u201cnegative\u201d exome: a review on genetic diagnostics, limitations, challenges, and emerging new multiomics techniques. J Inher Metab Disea. 2022;45(4):663\u201381. https:\/\/doi.org\/10.1002\/jimd.12507.","journal-title":"J Inher Metab Disea"},{"key":"4387_CR110","doi-asserted-by":"publisher","unstructured":"Cummings BB, Marshall JL, Tukiainen T, Lek M, Donkervoort S, Foley AR, et al. Improving genetic diagnosis in mendelian disease with transcriptome sequencing. Sci Transl Med. 2017;9(386). https:\/\/doi.org\/10.1126\/scitranslmed.aal5209.","DOI":"10.1126\/scitranslmed.aal5209"},{"issue":"6","key":"4387_CR111","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1038\/s41591-019-0457-8","volume":"25","author":"L Fr\u00e9sard","year":"2019","unstructured":"Fr\u00e9sard L, Smail C, Ferraro NM, Teran NA, Li X, Smith KS, et al. Identification of Rare-disease genes using blood transcriptome sequencing and large control cohorts. Nat Med. 2019;25(6):911\u201319. https:\/\/doi.org\/10.1038\/s41591-019-0457-8.","journal-title":"Nat Med"},{"issue":"5","key":"4387_CR112","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.ajhg.2019.04.004","volume":"104","author":"HD Gonorazky","year":"2019","unstructured":"Gonorazky HD, Naumenko S, Ramani AK, Nelakuditi V, Mashouri P, Wang P, et al. Expanding the boundaries of RNA sequencing as a diagnostic tool for rare mendelian disease. Am J Hum Genet. 2019;104(5):1007. https:\/\/doi.org\/10.1016\/j.ajhg.2019.04.004.","journal-title":"Am J Hum Genet"},{"issue":"1","key":"4387_CR113","doi-asserted-by":"publisher","first-page":"15824","DOI":"10.1038\/ncomms15824","volume":"8","author":"LS Kremer","year":"2017","unstructured":"Kremer LS, Bader DM, Mertes C, Kopajtich R, Pichler G, Iuso A, et al. Genetic diagnosis of Mendelian disorders via RNA sequencing. Nat Commun. 2017;8(1):15824. https:\/\/doi.org\/10.1038\/ncomms15824.","journal-title":"Nat Commun"},{"issue":"1","key":"4387_CR114","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13073-022-01019-9","volume":"14","author":"VA Y\u00e9pez","year":"2022","unstructured":"Y\u00e9pez VA, Gusic M, Kopajtich R, Mertes C, Smith NH, Alston CL, et al. Clinical implementation of RNA sequencing for Mendelian disease diagnostics. Genome Med. 2022;14(1):38. https:\/\/doi.org\/10.1186\/s13073-022-01019-9.","journal-title":"Genome Med"},{"issue":"1","key":"4387_CR115","doi-asserted-by":"publisher","first-page":"15900","DOI":"10.1038\/s41598-025-99882-0","volume":"15","author":"R Doshi","year":"2025","unstructured":"Doshi R, Kinnear E, Chatterjee S, Guha P, Liu Q. Reliable investigation of DNA methylation using Oxford Nanopore technologies. Sci Rep. 2025;15(1):15900. https:\/\/doi.org\/10.1038\/s41598-025-99882-0.","journal-title":"Sci Rep"},{"issue":"4","key":"4387_CR116","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/j.gim.2021.12.011","volume":"24","author":"AJ Robertson","year":"2022","unstructured":"Robertson AJ, Tan NB, Spurdle AB, Metke-Jimenez A, Sullivan C, Waddell N. Re-analysis of genomic data: an overview of the mechanisms and complexities of clinical adoption. Genet Med: Off J Am Coll Med Genet. 2022;24(4):798\u2013810. https:\/\/doi.org\/10.1016\/j.gim.2021.12.011.","journal-title":"Genet Med: Off J The Am Coll Med Genet"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-026-04387-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04387-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04387-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T22:47:07Z","timestamp":1789685227000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13023-026-04387-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,24]]},"references-count":116,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4387"],"URL":"https:\/\/doi.org\/10.1186\/s13023-026-04387-2","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,24]]},"assertion":[{"value":"26 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Urugenomes project was approved by the Ethics Committee of the Institut Pasteur de Montevideo (URUGENOMES Project IP011-17\/CEI\/LC\/MB). Later, in 2021, an addendum was issued by the ethics committee for the use of WES instead of WGS. Ethics Committe of the Facultad de Medicina approved the use of WES in patients from Policl\u00ednica de Gen\u00e9tica of Departamento de Gen\u00e9tica. The Uruguayan genomic data supporting the findings of this study are not publicly available due to privacy and ethical restrictions. Aggregated, population-level data can be shared upon request. Access to individual-level patient data requires approval from the Ethics Committee of the Institut Pasteur de Montevideo, as well as informed consent from the parents or legal guardians.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"319"}}